Sector |
|
Compare with Sector peers |
Industry |
|
Compare with Industry peers |
Website | http://www.scandent.in | |
Market Cap | 48.88 Cr. | |
Enterprise Value(EV) | 53.14 Cr. | 2023-09 |
Financial Indicators | ||
---|---|---|
Earnings per share (EPS) | 0.94 | Trailing Twelve Months Ending 2023-09 |
Price-Earning Ratio (PE) | 9.59 | Trailing Twelve Months Ending 2023-09 |
Industry PE | 63.13 | Trailing Twelve Months Ending 2023-09 |
Book Value / Share | 8.96 | Trailing Twelve Months Ending 2023-09 |
Price to Book Value | 1.01 | Calculated using Price: 9.05 |
Dividend Yield | 0.00 | Period Ending 2023-03 |
No. of Shares Subscribed | 5.40 Cr. | 54,014,774 Shares |
FaceValue | 10 | |
About Family Care Hospitals Ltd. | ||
Scandent Imaging is pioneer in providing independent state of the art dental and ENT Imaging solutions. The company provides an exhaustive range of 3D and 2D scan services along with expert reports to cater to the requirements of the dental and ENT fraternity. They specialized and intend to provide complete scanning solutions to the growing demands of the dental and ENT fraternity. Scandent offers the best of technology and scanning experience. The company has designed unique imaging packages that match the requirements of the dental and ENT fraternity as well as the affordability of its end users. |
1 Day |
|
-2.16% |
1 Week |
|
-3.93% |
1 Month |
|
+22.46% |
3 Month |
|
+32.12% |
6 Month |
|
-23.69% |
1 Year |
|
-29.68% |
2 Year |
|
-48.49% |
5 Year |
|
-44.10% |
10 Year |
|
+469.18% |
9 years | 2015-03 | 2016-03 | 2017-03 | 2018-03 | 2019-03 | 2020-03 | 2021-03 | 2022-03 | 2023-03 | |
Return on Equity (%) | -1,394.79 | 0.51 | 3.92 | 18.96 | 0.38 | 0.57 | 57.85 | 44.60 | 17.51 | |
Return on Capital Employed (%) | -1,096.64 | 0.58 | 4.85 | 25.41 | 7.15 | 7.03 | 44.54 | 45.74 | 23.20 | |
Return on Assets (%) | -1,085.04 | 0.44 | 3.13 | 11.15 | 0.16 | 0.18 | 21.72 | 17.27 | 9.21 |
Particulars | 10 years | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. | 2023-09* Rs. Cr. |
Shh. Funds | 4 | 4 | 4 | 5 | 5 | 5 | 9 | 14 | 46 | 48 | |
Non Curr. Liab. | 0 | 0 | 0 | 6 | 7 | 6 | 6 | 8 | 9 | ||
Curr. Liab. | 1 | 1 | 1 | 5 | 3 | 5 | 5 | 20 | 21 | 19 | |
Minority Int. | |||||||||||
Equity & Liab. | 5 | 5 | 6 | 10 | 14 | 17 | 20 | 40 | 74 | 77 | |
Non Curr. Assets | 2 | 2 | 3 | 9 | 10 | 11 | 9 | 8 | 16 | 15 | |
Curr. Assets | 3 | 3 | 2 | 0 | 3 | 6 | 11 | 32 | 59 | 61 | |
Misc. Exp. not W/O | |||||||||||
Total Assets | 5 | 5 | 6 | 10 | 14 | 17 | 20 | 40 | 74 | 77 |
Particulars | 10 years | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. | 2023-09 Rs. Cr. TTM |
Net Sales | 0 | 1 | 2 | 5 | 14 | 13 | 35 | 42 | 47 | 49 | |
Other Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | |
Total Income | 0 | 1 | 2 | 5 | 14 | 13 | 35 | 42 | 48 | 50 | |
Total Expenditure | 0 | -1 | -2 | -4 | -13 | -11 | -27 | -33 | -39 | -41 | |
PBIDT | 0 | 0 | 0 | 2 | 2 | 2 | 8 | 9 | 9 | 9 | |
Interest | 0 | 0 | 0 | -1 | -1 | -1 | -1 | -1 | -1 | ||
Depreciation | 0 | 0 | 0 | 0 | -1 | -1 | -1 | -1 | -1 | -1 | |
Taxation | 0 | 0 | 0 | 0 | -2 | -2 | -2 | -2 | |||
Exceptional Items | -25 | ||||||||||
PAT | -25 | 0 | 0 | 1 | 0 | 0 | 4 | 5 | 5 | 5 | |
Adjusted EPS | -7 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 1 |
Particulars | 10 years | 2014-03 Rs. Cr. | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. |
Cash Fr. Operatn. | 0 | 0 | 0 | 0 | 3 | -3 | 0 | 4 | 2 | -5 | |
Cash Fr. Inv. | -2 | 0 | -1 | -5 | -2 | -2 | 0 | 0 | -2 | ||
Cash Fr. Finan. | 0 | 5 | 1 | 0 | 5 | 3 | -5 | -2 | 26 | ||
Net Change | 0 | 3 | 0 | 0 | -2 | 0 | 1 | -1 | 0 | 19 | |
Cash & Cash Eqvt | 0 | 3 | 3 | 2 | 0 | 0 | 2 | 0 | 0 | 19 |
Fri, 24 Nov 2023
Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations 2011. The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 on November 21 2023 for Gautam Deshpande |
Mon, 13 Nov 2023
Submission Of Statement Of Deviation/Variation Pursuant To Regulation 32 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 Statement of Deviation/Variation pursuant to Regulation 32 of SEBI (LODR) Regulations 2015 |
Mon, 30 Oct 2023
Announcement under Regulation 30 (LODR)-Newspaper Publication Newspaper Publication for Intimation of of Standalone Unaudited Financial Results of Second Quarter and Half Year ended 30th September 2023 |
Wed, 06 Dec 2023 |
|
|
|
|
|